Esperion Therapeutics reported $-55592000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acceleron Pharma XLRN:US $ -69.47M 6.84M
Adamas Pharmaceuticals ADMS:US -5502000 3.51M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Alnylam Pharmaceuticals ALNY:US $ -169.89M 35.54M
Amarin AMRN:US $ 1.82M 7.74M
Amgen AMGN:US $ 3228M 40M
Arena Pharmaceuticals ARNA:US $ -123.51M 19.9M
Biogen BIIB:US $ 991.8M 155.8M
Biomarin Pharmaceutical BMRN:US $ -9.16M 48.05M
Daiichi Sankyo 4568:JP Y 53261M 7192M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Esperion Therapeutics ESPR:US $ -55592000 23.21M
Flexion Therapeutics FLXN:US $ -23631000 7.27M
Geron GERN:US $ -25.62M 3.22M
Halozyme Therapeutics HALO:US $ 76.34M 17.51M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Intra Cellular Therapies ITCI:US $ -77.19M 8.17M
Minerva Neurosciences NERV:US $ -7.52M 1.44M
Moderna Inc MRNA:US 3.63B 497M
Nektar Therapeutics NKTR:US $ -109.98M 3.32M
Pfizer PFE:US $ 10235M 2245M
Ptc Therapeutics PTCT:US $ -76.33M 7.18M
Puma Biotechnology PBYI:US $ -6.51M 7.18M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Seattle Genetics SGEN:US $ -281.36M 207.58M
United Therapeutics UTHR:US $ 242.3M 7.7M
Vanda Pharmaceuticals VNDA:US $ 11.19M 1.89M
Zogenix ZGNX:US $ -51.9M 1.17M